Inventor · disambiguated record
Damodar Gullipalli
Also filed as: GULLIPALLI DAMODAR
6 granted patents·7 pending applications·13 citations·filing 2016–2024
76Inventor score
Top patents by PatentIndex Score
13 records- 0189US11578137B2Anti-C5 antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Feb 14, 2023·7 cites·23 claims
- 0288US10988519B2Composition and method for treating complement-mediated diseaseUNIV PENNSYLVANIA·Filed 2016·Granted Apr 27, 2021·3 cites·23 claims
- 0383US12180254B1Factor H variants for treatment of diseaseUNIV PENNSYLVANIA·Filed 2023·Granted Dec 31, 2024·0 cites·24 claims
- 0483US2025051408A1Factor h variants for treatment of diseaseUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0577US11434279B2Anti-factor D antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Sep 6, 2022·2 cites·16 claims
- 0674US12098190B2Humanized anti-C5 antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2019·Granted Sep 24, 2024·1 cites·20 claims
- 0770US2021171592A1Composition and method for treating complement-mediated diseaseUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 0868US2023227571A1Anti-c5 antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0968US2023032737A1Anti-factor d antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1064US2022153824A1Anti-c5a antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1163US2025376539A1Anti-c2 antibodies and uses thereofKIRA PHARMACEUTICALS SUZHOU LTD·Filed 2023·Application pending·0 cites
- 1257US11274146B2Anti-C5a antibodies and uses thereofUNIV PENNSYLVANIA·Filed 2018·Granted Mar 15, 2022·0 cites·18 claims
- 1348US2022204602A1Bi-functional humanized anti-c5 antibodies and factor h fusion proteins and uses thereofUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Damodar Gullipalli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →